In the case of ITCH, the pro-autophagic and oncogenic roles in breast, prostate, and bladder cancer cells have been found and, thus, suggest ITCH inhibitors as the potential therapeutic tool in these cancer (Rossi et al. 2014). This evidence concerns the gene ITCH and urinary bladder cancer.